To interview admits to severe bilateral claudication with lt 05 block walking Rutherford 3 Meds Aspirin 81mg Ezetimibe 10mg Fenofibrate 145mg Vascepa 2gm Isosorbide mononitrate ID: 914400
Download Presentation The PPT/PDF document "Case Presentation 64 M with HTN, HLD, CK..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Case Presentation
64 M with HTN, HLD, CKD IV known abdominal aortic and Iliac aneurysm presents with claudication To interview admits to severe bilateral claudication with < 0.5 block walking (Rutherford 3)Meds: Aspirin 81mg, Ezetimibe 10mg, Fenofibrate 145mg, Vascepa 2gm, Isosorbide mononitrate ER 60mg Exam: 1+ PT pulses bilaterally, Doppler DP pulses bilaterallyABI: 0.65 R, 0.54 L
Slide2Case Presentation, continued
Ultrasound: AAA 4.2cm50-99% R SFA stenosisR SFA aneurysm 2.4cm50-99% L SFA stenosisL SFA aneurysm 2.9cm with mural thrombusR pop aneurysm 2.1cmL pop aneurysm 2.9cm
Slide3Ultrasound
Slide4Ultrasound
Slide5Heart/Vascular team discussion
Due to patient frailty and strong patient preference to avoid surgery, planned for attempted endovascular treatment of obstructive femoropopliteal disease with associated aneurysms
Slide6Case Plan
Endovascular intervention of femoro-popliteal obstructive disease with large SFA and popliteal aneurysms.
Bailey et al.
JACC
2019:214–37216
Slide7Popliteal artery aneurysm – epidemiology
Most common peripheral aneurysm Male predominantPrevalence: 1% of men 65-80 yearsCorrelation with AAA In patients with AAA, prevalence of PAA in 9-14%In patients with PAA, AAA in ~40%
Diwan
A, Sarkar R, Stanley JC,
Zelenock
GB, Wakefield TW J
Vasc
Surg. 2000;31(5):863.
Lawrence PF, Lorenzo-
Rivero
S, Lyon JL J
Vasc
Surg. 1995;22(4):409.
Dawson I,
Sie
RB, van
Bockel
JH Br
J Surg. 1997;84(3):293.
Slide8Popliteal artery aneurysm – clinical
presentationAsymptomatic – 30-40% of PAA asymptomatic at time of diagnosis Symptomatic
– PAA >2.0cm correlated with higher risk of complications
Thrombosis
Occurs in up to 33% of PAA patients followed conservatively
D
epending on time course can cause acute ischemic presentation (66%) or claudication (33%)
Risk factors: diameter >2cm, presence of thrombus, poor runoff
Limb loss in 20-60% of patients with acute ischemia
Embolism
Mass effect
Only with large aneurysm (>3)
Pain, fullness behind knee
Compression of veins, sciatic, peroneal or
tibial
nerve
Rupture
<5% of PAA patients
Older patients, larger diameter PAA
Dawson I,
Sie
RB, van
Bockel
JH Br J Surg. 1997;84(3):293.
Slide9Popliteal artery aneurysm – diagnosis
Popliteal artery diameter 1.5x normal on non-invasive imagingScreening of contralateral popliteal, bilateral femoral arteries and abdominal aorta is important in presence of newly diagnosed PAA
Farber
et al. J
Vasc
Surg
2021;-:1-12.
Slide10Popliteal artery aneurysm –
conservative managementPitthankal et al. serial duplex scanning of small PAAPAA < 2cm: 1.5mm/yr diameter increase
PAA 2-3cm: 3mm/
yr
diameter increase
PAA > 3cm: 3.7mm/
yr
diameter increase
Stiegler
et al. serial duplex scanning of asymptomatic PAA
PAA < 2cm: 0.7mm/
yr
diameter increase, 3.1% developed symptoms in 2
yrs
PAA > 2cm: 1.5mm/
yr
diameter increase, 14.2% developed symptoms in 2
yrs
Symptoms developed only in patient with thrombus in aneurysms on duplex
Pitthankal
et al.
Eur
J
Vasc
Endovasc Surg. 2004;27:382–384.
Stiegler
et al.
Vasa
. 2002;31:43
– 46
.
Slide11Popliteal artery aneurysm –
acute thrombosis
Farber
et al. J
Vasc
Surg
2021;-:1-12.
Carpenter et al. analysis of 45 aneurysms treated surgically. 7 patients with thrombosed aneurysm and outflow treated with pre-operative
thrombolytics
with better graft patency and limb salvage compared to comparable patients treated with emergency operations alone
Poor results of limb salvage if thrombolysis doesn’t restore flow
Carpenter
et al J
vasc
surg
1994 Jan;19(1):65-72
Slide12Popliteal artery aneurysm –
surgical managementMedial vs. posterior approachAneurysm exclusion vs. in-line reconstruction SVG vs. PTFE graft
Slide13Popliteal artery aneurysm –
surgical management
Phair
et al. J
Vasc
Surg
2016;64:1141-50
Slide14Popliteal artery aneurysm –
surgical management
Hernando et al. J
Vasc
Surg
2015;61:655-61
N= 171 aneurysms
57.9% SVG graft vs 23.4% surgical PTFE vs 18.7% stent graft
Slide15Popliteal artery aneurysm –
endovascularCriteria for successful endovascular approachFocal aneurysm that does not extend into distal poplitealNon-tortuous poplitealAt least 2 vessel runoff1cm overlap of stent graft with ‘normal’ artery on both sides
Post-thrombolysis approach dependent on restoration of flow
Hybrid approach for ruptured aneurysm
Slide16Popliteal artery aneurysm –
OPAR vs EPAR
Leake
et al.
Vasc
Surg
2017;65:246-56
Slide17Popliteal artery aneurysm –
OPAR vs EPAR
Primary patency 1 year
Primary patency 3 years
Beuschel
et al. J
Vasc
Surg
2021;-:1-5
Slide18Popliteal artery aneurysm –
OPAR vs EPAR
Hernando et al. J
Vasc
Surg
2015;61:655-61
Slide19Popliteal artery aneurysm –
OPAR vs EPAR
Joshi et al
. Cochrane
Database of Systematic Reviews
2019, Issue 12.
Slide20Popliteal artery aneurysm –
OPAR vs EPAR
Farber
et al. J
Vasc
Surg
2021;-:1-12.
Slide21Popliteal artery aneurysm –
endovascular complicationsStent thrombosisAggressive oversizing (incomplete unfolding)Stent kinking (angulation at adductor canal)Poor outflowEndoleak
Occurs in 10-20% of PAA repairs
Most common is type I (at graft fixation sites) – can be immediate or delayed
Type II can be treated with thrombin injection or coiling
Stent Fracture – unclear association with patency
Slide22Farber
et al. J
Vasc
Surg
2021;-:1-12.
Slide23Leake et al. Vasc Surg 2017;65:246-56.
Slide24Thank you